News & Filings
SYNGENE \u2014 Recent Activity
4 items in the last 14 days
Biocon Ltd (BOM:532523) Q3 2026 Earnings Call Highlights: Strong Revenue Growth Amidst ...
Biocon Ltd (BOM:532523) reports a robust 9% increase in operating revenue, driven by biosimilars and generics, while navigating challenges in CRDMO and regulatory hurdles.
Click to open →
Syngene International Ltd (BOM:539268) Q3 2026 Earnings Call Highlights: Navigating Revenue ...
Despite a decline in quarterly revenue, Syngene International Ltd (BOM:539268) focuses on strategic partnerships and capacity expansion to drive future growth.
Click to open →
Indian drugmaker Divi's beats profit view for second quarter on API boost
(Reuters) -Indian drugmaker Divi's Laboratories reported second-quarter profit above analysts' estimates on Friday, helped by its business that focuses on customised production of chemical compounds
Click to open →
Syngene International Ltd (BOM:539268) Q2 2026 Earnings Call Highlights: Navigating Growth ...
Despite revenue growth and strategic expansions, Syngene International Ltd faces declining profits and increased operational costs.
Click to open →
Get alerts for important filings
Add SYNGENE to your watchlist for board meeting & dividend alerts.
Open analysis →News from yfinance + BSE corporate announcements. Importance scoring is automated. YieldIQ is not registered with SEBI as an investment adviser.